recent
report
indic
replic
hepat
c
viru
hcv
depend
pathway
gener
cell
line
resist
brefeldin
bfa
inhibitor
pathway
resist
cell
line
could
sort
two
phenotyp
regard
bfainduc
toxic
inhibit
albumin
secret
inhibit
hcv
infect
two
cell
line
time
resist
bfa
parent
cell
assay
resist
phenotyp
correl
presenc
point
mutat
domain
known
impair
bind
bfa
surprisingli
morpholog
cisgolgi
cell
remain
sensit
bfa
concentr
drug
allow
albumin
secret
indic
dichotomi
phenotyp
secret
golgi
morpholog
cell
second
group
time
resist
parent
cell
bfainduc
toxic
ec
albumin
secret
fold
higher
cell
cell
howev
level
secret
presenc
inhibitori
dose
bfa
time
higher
despit
partial
effect
secretori
pathway
presenc
bfa
hcv
infect
almost
sensit
bfa
cell
suggest
function
hcv
replic
simpli
reflect
role
regul
secretori
pathway
host
cell
thu
result
confirm
involv
hcv
replic
suggest
might
fulfil
anoth
function
addit
regul
secretori
pathway
hcv
replic
replic
singlestrand
posit
rna
virus
occur
associ
rearrang
intracellular
membran
hepat
c
viru
hcv
membran
rearrang
name
membran
web
differ
type
hcvinduc
membran
structur
observ
depend
experiment
model
membran
web
initi
describ
os
cell
induc
express
hcv
polyprotein
indic
format
depend
hcv
protein
express
even
without
rna
replic
compos
small
vesicl
embed
membran
matrix
similar
membran
alter
later
observ
cell
harbor
subgenom
replicon
genotyp
cell
repliconcontain
cell
report
contain
nonstructur
protein
genom
rna
moreov
newli
synthes
viral
rna
also
detect
membran
web
clearli
indic
site
viral
rna
synthesi
addit
membran
web
second
type
hcv
replicas
observ
cell
contain
gfptag
replicon
second
type
replicas
made
smaller
structur
much
mobil
membran
web
scatter
throughout
cell
highli
permiss
cell
replic
subgenom
replicon
strain
high
level
membran
alter
shown
much
extens
occurr
numer
doubl
membran
vesicl
multivesicular
structur
observ
replicon
genotyp
doubl
membran
vesicl
togeth
singl
membran
vesicl
also
observ
lunet
cell
unclear
whether
differ
morpholog
alter
observ
variou
studi
primarili
result
host
cell
viral
genotyp
format
function
membran
web
still
poorli
understood
two
viral
protein
appear
play
major
role
induct
membran
rearrang
base
morpholog
data
show
close
associ
er
hcv
replicas
biochem
data
indic
hcv
rna
replic
take
place
compart
sustain
endoglycosidas
hsensit
glycosyl
membran
web
propos
deriv
er
membran
howev
sever
endosom
marker
also
observ
coloc
hcv
replicas
andor
function
involv
rna
replic
one
major
host
factor
implic
hcv
rna
replic
kinaseiiia
also
known
enzym
er
interact
activ
hcv
replic
deplet
rna
interfer
lead
morpholog
aberr
structur
cell
express
hcv
polyprotein
recent
other
found
role
pathway
hcv
replic
guanin
nucleotid
exchang
factor
gef
recruit
membran
cisgolgi
activ
gprotein
activ
bind
gtp
turn
recruit
differ
effector
includ
coat
protein
complex
copi
form
vesicular
carrier
pathway
mediat
retrograd
transport
cisgolgi
ergic
er
also
implic
biogenesi
lipid
droplet
inhibit
brefeldin
induc
collaps
golgi
complex
redistribut
golgi
glycosidas
er
block
secretori
pathway
level
er
exit
precis
role
pathway
hcv
replic
still
unclear
sever
singlestrand
posit
rna
virus
picornavirida
coronavirida
famili
also
reli
pathway
replic
inhibit
hcv
replic
brefeldin
much
stronger
begin
infect
infect
alreadi
establish
suggest
crucial
role
onset
replic
rna
virus
establish
chronic
infect
unlik
hcv
share
special
requir
earli
infect
appear
compon
hcv
replic
complex
coloc
marker
hcv
replic
complex
confoc
microscopi
format
membran
weblik
structur
os
cell
express
hcv
polyprotein
inhibit
brefeldin
suggest
role
pathway
function
replic
complex
rather
format
similarli
seem
requir
format
membran
replic
complex
singlestrand
posit
rna
virus
polioviru
mous
hepat
viru
gain
insight
role
pathway
hcv
replic
gener
cell
line
resist
brefeldin
analyz
hcv
replic
membran
traffic
cell
line
found
classifi
two
phenotyp
one
result
mutat
code
sequenc
dulbecco
modifi
eagl
medium
dmem
phosphatebuff
salin
pb
trypsinedta
optimem
oligofectamin
goat
serum
fetal
calf
serum
fc
purchas
life
technolog
dapi
molecular
probe
golgicid
mowiol
calbiochem
proteas
inhibitor
cocktail
complet
roch
chemic
sigma
mous
mab
produc
vitro
use
miniperm
apparatu
heraeu
recommend
manufactur
sheep
antiserum
kindli
provid
dr
harri
univers
leed
mous
transferrin
receptor
mab
purchas
santa
cruz
biotechnolog
sheep
serotec
mous
mab
transduct
laboratori
rabbit
bethyl
laboratori
mous
mab
abcam
mous
antib
tubulin
mab
tub
sigma
mous
antihsa
invitrogen
goat
antihsa
calbiochem
goat
antiapo
millipor
alexa
donkey
antisheep
igg
antibodi
invitrogen
peroxidaseconjug
goat
antimous
antirabbit
antisheep
igg
cyanin
goat
antimous
igg
jackson
immunoresearch
mdck
kindli
provid
dr
fafeur
institut
de
biologi
de
lill
franc
cell
grown
dulbecco
modifi
eagl
medium
dmem
high
glucos
modif
supplement
glutamaxi
sodium
pyruv
heatinactiv
fetal
bovin
serum
bfaresist
cell
select
grown
presenc
bfa
ngml
cultur
medium
viru
use
studi
base
contain
cell
cultur
adapt
mutat
reconstitut
epitop
describ
previous
luciferasebas
assay
perform
use
hcvcc
contain
cell
cultur
adapt
mutat
express
renilla
luciferas
report
hcvccrluc
previous
describ
infram
delet
introduc
corecod
region
hcvccrluc
construct
previous
describ
nonrepl
control
contain
gnd
mutat
activ
site
previous
report
hcvcc
infect
assay
subconflu
cell
grown
plate
incub
ml
hcvccrluc
presenc
bfa
hour
inocul
replac
fresh
cultur
medium
infect
cell
cultur
presenc
bfa
hpi
cell
lyse
ul
renilla
lysi
buffer
promega
hpi
infect
score
measur
luciferas
activ
use
renilla
luciferas
assay
kit
indic
manufactur
promega
replic
assay
cell
electropor
hcvccrlucdcor
hcvcrlucgnd
rna
plate
plate
presenc
increas
concentr
bfa
bfa
remov
h
later
cell
cultur
without
bfa
luciferas
activ
measur
h
h
h
h
postelectropor
luciferas
activ
hpi
express
measur
time
point
normal
accordingli
rna
interfer
experi
carri
pool
four
differ
synthet
doublestrand
sirna
target
ontarget
plu
smart
pool
reagent
dharmacon
previous
describ
singl
nontarget
sirna
impact
hcv
infect
use
neg
control
briefli
subconflu
cultur
cell
sixwel
cluster
transfect
pmol
sirna
complex
ml
oligofectamin
total
volum
ml
optimem
per
well
h
cell
trypsin
h
sirna
transfect
plate
cluster
analyz
immunofluoresc
day
sirna
transfect
quantifi
hcvcc
infect
sirnatr
cell
infect
h
trypsin
infect
extra
well
cell
treat
sirna
count
ensur
equal
number
cell
infect
rel
express
level
target
protein
analyz
immunoblot
equal
amount
cell
lysat
hcvcc
infect
quantifi
measur
express
level
immunoblot
hpi
cell
process
indirect
immunofluoresc
detect
viral
protein
cellular
marker
previous
describ
imag
acquir
confoc
microscop
zeiss
use
numer
apertur
oil
immers
object
signal
sequenti
collect
use
singl
fluoresc
excit
acquisit
set
avoid
crossov
imag
assembl
use
adob
photoshop
softwar
cell
lyse
lysi
buffer
mm
triscl
buffer
ph
contain
mm
nacl
mm
edta
triton
sodium
dodecyl
sulfat
proteas
inhibitor
min
ice
cell
collect
nuclei
pellet
protein
concentr
postnuclear
supernat
determin
bicinchonin
acid
method
recommend
manufactur
sigma
use
bovin
serum
albumin
standard
protein
separ
sdspolyacrylamid
gel
electrophoresi
transfer
nitrocellulos
membran
hybondecl
amersham
use
transblot
apparatu
biorad
protein
interest
reveal
specif
primari
antibodi
follow
speciesspecif
secondari
antibodi
conjug
peroxidas
enhanc
chemiluminesc
detect
recommend
manufactur
thermofisch
signal
record
imag
fujifilm
unsatur
signal
quantifi
gel
macro
imagej
softwar
subconflu
cell
cultur
grown
plate
incub
bfa
h
mt
base
viabil
assay
celltit
aqueou
nonradioact
cell
prolifer
assay
promega
conduct
recommend
manufactur
subconflu
cell
cultur
grown
plate
incub
h
ml
complet
cultur
medium
contain
bfa
cultur
media
collect
centrifug
remov
cell
debri
cell
rins
pb
lyse
lysi
buffer
min
ice
hsa
concentr
supernat
lysat
determin
elisa
use
human
serum
albumin
hsa
standard
describ
percentag
secret
calcul
percentag
hsa
medium
divid
total
amount
hsa
medium
lysat
total
rna
extract
use
nucleospin
rna
ii
kit
describ
manufactur
machereynagel
cdna
obtain
use
expand
revers
transcriptas
amplifi
pcr
use
high
fidel
dna
polymeras
roch
overlap
pcr
product
purifi
agaros
gel
sent
genoscreen
perform
sanger
sequenc
sequenc
primer
use
revers
transcript
step
pcr
sequenc
step
describ
tabl
cell
transfect
express
vector
yellow
fluoresc
protein
yfp
yfptag
inact
mutant
bfaresist
mutant
use
transfect
reagent
recommend
manufactur
miru
isol
cell
line
resist
brefeldin
bfaresist
cell
select
cultiv
cell
presenc
low
dose
bfa
cell
die
less
week
cell
surviv
grown
passag
continu
presenc
bfa
least
month
character
seven
independ
cell
line
name
select
tabl
toxic
bfa
assess
measur
cell
viabil
hincub
presenc
increas
concentr
drug
cellular
viabil
cell
decreas
presenc
mgml
bfa
higher
dose
figur
two
select
cell
line
cell
show
partial
decreas
viabil
concentr
mgml
bfa
impact
lower
dose
figur
cell
line
resist
bfa
intermedi
parent
cell
resist
cell
viabil
reduc
concentr
mgml
mgml
bfa
littl
effect
concentr
mgml
even
cell
line
select
ngml
bfa
concentr
figur
expect
bfa
effect
growth
mdck
cell
use
control
experi
result
allow
us
divid
resist
cell
line
group
depend
degre
resist
bfa
cell
group
time
resist
growth
inhibit
bfa
cell
group
time
resist
assess
sensit
hcv
infect
bfa
resist
cell
line
resist
cell
line
infect
recombin
hcvcc
express
renilla
luciferas
presenc
increas
dose
bfa
luciferas
activ
quantifi
hpi
time
postinfect
reinfect
event
allow
assess
activ
drug
replic
step
hcv
life
cycl
previous
report
hcvcc
infect
cell
inhibit
dosedepend
manner
lowest
inhibitori
concentr
bfa
mgml
figur
similar
inhibitori
pattern
observ
cell
group
although
rel
hcv
infect
slightli
higher
resist
cell
group
control
cell
dose
mgml
bfa
ec
similar
cell
line
rang
mgml
cell
mgml
cell
appear
slightli
resist
hcv
infect
ec
mgml
contrast
hcvcc
infect
much
less
suscept
bfa
cell
partial
inhibit
hcv
infect
observ
concentr
mgml
figur
therefor
resist
cell
display
dramat
differ
sensit
bfa
regard
hcvcc
infect
group
cell
resist
bfa
inhibit
hcv
infect
group
cell
sensit
similar
cell
bfa
previous
shown
inhibit
hcv
infect
replic
step
confirm
resist
bfa
inhibit
hcv
replic
cell
electropor
cell
vitro
transcrib
genom
rna
hcvcc
construct
express
renilla
luciferas
delet
major
part
core
code
sequenc
order
avoid
bfa
impact
viral
egress
reinfect
electropor
cell
treat
hour
increas
concentr
bfa
drug
remov
luciferas
activ
monitor
measur
replic
previous
describ
replic
inhibit
bfa
dosedepend
manner
cell
figur
contrast
replic
insensit
bfa
cell
shown
similar
curv
luciferas
activ
regardless
concentr
bfa
figur
result
indic
resist
bfa
inhibit
hcv
infect
cell
result
lack
action
bfa
replic
step
hcv
life
cycl
previous
establish
bfa
sensit
hcv
infect
result
inhibit
function
addit
known
arfgef
mammalian
cell
bfainsensit
therefor
resist
hcv
infect
bfa
inhibit
cell
could
result
shift
arfgef
usag
anoth
bfainsensit
arfgef
hcv
replic
confirm
hcv
infect
cell
still
depend
perform
sirnamedi
deplet
analyz
impact
hcv
infect
quantifi
express
previous
report
reduct
express
induc
inhibit
hcv
infect
cell
figur
deplet
anoth
bfasensit
arfgef
involv
hcv
replic
slight
nonsignific
effect
compar
untransfect
control
wherea
deplet
host
factor
essenti
hcv
replic
inhibit
express
experiment
set
figur
level
inhibit
impos
deplet
similar
cell
figur
result
indic
despit
resist
bfa
inhibit
hcv
infect
cell
still
depend
addit
hcv
replic
also
requir
function
therefor
test
whether
hcv
replic
cell
still
depend
use
sirnamedi
deplet
result
inhibit
hcv
infect
cell
compar
cell
transfect
control
nontarget
sirna
despit
appar
moder
effici
sirna
figur
howev
actual
effici
deplet
probabl
underestim
sinc
antibodi
use
crossreact
arf
famili
member
similar
inhibitori
pattern
observ
cell
figur
indic
hcv
infect
depend
cell
result
indic
hcv
infect
resist
cell
requir
parent
bfasensit
cell
suggest
absenc
bfa
inhibit
could
result
select
cell
express
bfaresist
form
sinc
bfa
block
secret
manner
test
function
secretori
pathway
resist
cell
presenc
bfa
quantifi
secret
human
serum
albumin
hsa
use
elisa
assay
hsa
strongli
express
cell
constitut
secret
bfa
block
protein
transport
effect
protein
synthesi
therefor
measur
hsa
cell
lysat
supernat
quantifi
hsa
secret
percentag
secret
protein
period
hsa
secret
almost
complet
block
bfa
cell
mgml
higher
concentr
figur
resist
cell
line
express
similar
reduc
level
albumin
compar
cell
figur
concern
hsa
secret
two
group
resist
cell
display
differ
sensit
bfa
hsa
secret
cell
show
small
reduct
concentr
mgml
bfa
effect
lower
dose
contrast
cell
group
show
partial
residu
hsa
secret
concentr
mgml
reach
maxim
inhibit
mgml
figur
ec
shift
mgml
cell
mgml
cell
line
howev
main
differ
cell
higher
rate
secret
presenc
mgml
bfa
residu
albumin
secret
concentr
bfa
compris
secret
absenc
bfa
wherea
cell
residu
secret
reduc
bfainduc
inhibit
protein
secret
cell
confirm
apolipoprotein
e
apo
compon
vldl
particl
secret
cell
cell
treat
hour
increas
concentr
bfa
level
apo
cell
condit
media
investig
immunoblot
shown
figur
apo
absent
medium
cell
treat
bfa
mgml
higher
concentr
level
apo
increas
correspond
cell
lysat
indic
inhibit
secret
apo
contrast
apo
remain
secret
cell
presenc
mgml
bfa
bfa
block
apo
secret
mg
ml
figur
result
confirm
reduct
bfainduc
inhibit
secret
cell
altogeth
data
indic
exist
differ
mechan
resist
bfa
two
group
cell
suggest
presenc
bfaresist
form
cell
lack
bfa
inhibit
secret
cell
could
result
mutat
reduc
interact
bfa
target
complex
investig
hypothesi
sequenc
code
sequenc
four
known
bfasensit
human
arf
three
isoform
report
detect
express
isoform
genbank
access
number
cell
complet
code
sequenc
determin
four
point
mutat
found
compar
refer
sequenc
mutat
led
aminoacid
substitut
posit
code
sequenc
isoform
tabl
mutat
present
togeth
wild
type
sequenc
data
shown
suggest
one
copi
gene
mutat
one
mutat
chang
residu
tyrosin
asparagin
hu
domain
function
unknown
mutat
residu
locat
two
residu
away
highli
conserv
hu
box
highli
conserv
region
gbfbig
gef
outsid
domain
three
mutat
lie
nonconserv
interdomain
region
set
mutat
found
cell
cell
group
cell
data
shown
therefor
conclud
none
mutat
could
account
moder
resist
bfa
cell
contrast
observ
cell
mutat
absent
cell
group
substitut
thymin
adenin
posit
sequenc
refer
mutat
lead
chang
methionin
atg
codon
leucin
ttg
codon
figur
mutat
affect
residu
domain
domain
interact
arf
bfa
cell
line
mutat
observ
togeth
wild
type
sequenc
suggest
one
copi
gene
mutat
cell
figur
also
sequenc
domain
two
bfasensit
arfgef
code
sequenc
human
arf
known
sensit
bfa
inhibit
addit
mutat
observ
resist
cell
line
data
shown
test
function
impact
mutat
yfptag
construct
contain
mutat
express
cell
cell
submit
bfa
challeng
construct
induc
protect
cell
bfainduc
toxic
compar
control
cell
express
yfp
figur
contrast
cell
express
yfptag
inact
mutant
respond
differ
yfpexpress
control
cell
similarli
express
rescu
hsa
secret
presenc
bfa
figur
data
confirm
impact
mutat
bfa
sensit
indic
mutat
present
cell
respons
bfa
resist
phenotyp
cell
bfa
treatment
known
alter
morpholog
golgi
endosom
analyz
impact
mutat
investig
sensit
organel
bfa
cell
cell
incub
min
presenc
mgml
bfa
process
immunofluoresc
detect
cisgolgi
marker
transgolgi
network
marker
transferrin
receptor
marker
recycl
endosom
alreadi
report
cell
line
cisgolgi
label
scatter
presenc
bfa
figur
wherea
tgn
structur
condens
perinuclear
dotlik
structur
figur
recycl
endosom
merg
larg
network
tubul
figur
also
partial
label
tgn
marker
expect
anoth
endosom
marker
unaffect
bfa
treatment
data
shown
morpholog
chang
tgn
recycl
endosom
similar
cell
figur
sensit
expect
sinc
depend
rather
surprisingli
pattern
label
scatter
cell
cell
cell
treat
min
reduc
concentr
mgml
bfa
pattern
label
similar
resist
cell
cell
wherea
mdck
cell
clearli
unaffect
figur
indic
sensit
cisgolgi
morpholog
cell
despit
mutat
similar
sensit
cisgolgi
morpholog
golgicid
mm
specif
inhibitor
function
also
observ
cell
data
shown
bfa
sensit
morpholog
golgi
complex
cell
bfa
concentr
inhibit
hsa
secret
unexpect
character
process
use
wide
rang
bfa
concentr
assess
rel
sensit
cisgolgi
mdck
cell
shown
figur
cell
turn
respons
bfa
howev
dramat
differ
sensit
ec
ngml
cell
rang
ngml
cell
mgml
mdck
cell
figur
tabl
interestingli
morpholog
cisgolgi
appear
approxim
time
sensit
bfa
secret
hsa
cell
time
cell
also
compar
rel
express
level
cell
immunoblot
shown
figur
cell
express
similar
level
indic
sensit
golgi
morpholog
cell
bfa
despit
mutat
result
increas
reduc
express
level
unfortun
could
compar
express
level
mdck
cell
antibodi
recogn
mdck
cell
also
investig
intracellular
local
immunofluoresc
found
differ
local
cell
absenc
bfa
presenc
mgml
bfa
data
shown
determin
inhibit
bfasensit
arfgef
could
particip
chang
cisgolgi
morpholog
respons
bfa
treatment
use
sirna
specif
deplet
expect
deplet
induc
dramat
scatter
label
reminisc
effect
bfa
treatment
figur
contrast
deplet
appar
effect
pattern
label
figur
indic
two
bfasensit
arfgef
regul
cisgolgi
morpholog
taken
togeth
result
indic
dichotomi
function
morpholog
effect
mutat
golgi
complex
studi
select
bfaresist
cell
line
analyz
phenotyp
regard
hcv
infect
membran
traffic
seven
independ
cell
line
gener
use
essenti
select
protocol
except
cell
line
select
use
reduc
concentr
bfa
two
differ
phenotyp
obtain
two
cell
line
highli
resist
bfa
time
bfa
cell
requir
observ
similar
effect
regard
cell
viabil
albumin
secret
hcv
infect
hand
five
cell
line
time
resist
bfainduc
toxic
sensit
parent
cell
regard
hcv
infect
resist
phenotyp
first
group
cell
correl
presenc
point
mutat
domain
replac
methionin
residu
leucin
residu
part
bfa
bind
site
interfac
crystal
structur
complex
domain
bfa
arfgdp
report
domain
modifi
bfasensit
arno
yeast
homolog
crystal
structur
conserv
methionin
residu
correspond
engag
van
der
waal
contact
bfa
substitut
leucin
residu
report
render
resist
bfa
domin
manner
accordingli
express
construct
cell
result
phenotyp
increas
resist
bfainduc
toxic
inhibit
hsa
secret
moreov
previous
show
express
render
cell
resist
bfainduc
inhibit
hcv
infect
therefor
presenc
mutat
cell
suffici
explain
bfaresist
phenotyp
cell
phenotyp
second
group
cell
associ
mutat
code
sequenc
bfasensit
arf
domain
resist
bfainduc
toxic
slightli
increas
could
result
increas
compensatori
mechan
select
cell
reduc
induct
unfold
protein
respons
upr
andor
uprinduc
apoptosi
respons
bfa
unusu
pattern
inhibit
albumin
secret
presenc
increas
dose
bfa
suggest
exist
compensatori
mechan
allow
secretori
pathway
cell
partial
function
concentr
bfa
fulli
inhibitori
cell
natur
put
compensatori
mechan
must
await
studi
surprisingli
although
secretori
pathway
cell
function
consist
observ
bfa
concentr
compris
mgml
disrupt
cisgolgi
appear
similar
observ
bfasensit
cell
indic
secretori
pathway
cell
bfaresist
function
presenc
bfa
spite
dramat
disorgan
golgi
complex
morpholog
includ
scatter
cisgolgi
collaps
transgolgi
network
result
clearli
indic
dichotomi
bfa
impact
cisgolgi
scatter
inhibit
hsa
secret
even
parent
bfasensit
cell
two
effect
bfa
observ
differ
concentr
interestingli
clear
correl
golgi
morpholog
function
secret
also
found
recent
sirna
screen
regul
golgi
architectur
previous
report
scatter
cisgolgi
marker
also
observ
sirnamedi
deplet
consist
role
regul
golgi
morpholog
report
previous
nonetheless
sensit
golgi
morpholog
bfa
cell
bfaresist
due
mutat
puzzl
especi
sinc
mdck
cell
also
leucin
residu
instead
methionin
posit
appear
golgi
morpholog
sensit
bfa
experiment
condit
howev
found
morpholog
cisgolgi
mdck
cell
also
sensit
bfa
extent
suggest
mutat
reduc
complet
abolish
bind
bfa
consist
observ
bfa
engag
contact
residu
bind
site
differ
sensit
cell
mdck
cell
remain
unexplain
fact
mdck
cell
express
cell
probabl
express
wild
type
mutant
protein
could
play
role
differ
sensit
exclud
possibl
differ
sequenc
protein
dog
human
origin
could
also
contribut
differ
sensit
addit
bfasensit
factor
might
also
regul
morpholog
cisgolgi
impact
secret
role
addit
bfasensit
factor
regul
cisgolgi
morpholog
hela
cell
recent
propos
howev
observ
impact
deplet
cisgolgi
morpholog
cell
precis
function
hcv
replic
still
elus
report
involv
replic
sever
posit
rna
virus
picornavirida
coronavirida
flavivirida
famili
virus
replic
genom
rna
take
place
vesicular
rearrang
membran
origin
least
part
membran
earli
secretori
pathway
howev
famili
virus
major
regul
earli
secretori
pathway
appear
major
role
format
rearrang
membran
infect
cell
rather
involv
function
structur
previous
hypothes
mechan
might
function
deliv
protein
lipid
hcv
replic
complex
result
cell
group
suggest
role
hcv
replic
simpli
reflect
role
regul
protein
secretori
pathway
inde
pattern
bfa
inhibit
hsa
secret
match
one
hcv
infect
cell
line
hcv
infect
complet
inhibit
mgml
bfa
wherea
hsa
secret
occur
rate
compris
secret
absenc
bfa
suggest
compensatori
mechan
exist
cell
allow
hsa
transport
er
presenc
bfa
sinc
main
step
secretori
pathway
inhibit
bfa
howev
compensatori
mechan
support
replic
hcv
even
reduc
rate
suggest
function
hcv
replic
reflect
function
secretori
pathway
could
also
fulfil
addit
function
hcv
replic
addit
function
could
either
relat
anoth
cellular
function
could
least
part
divert
normal
cellular
function
hcv
infect
worth
note
inhibit
polioviru
replic
bfa
larg
rescu
express
nterminu
includ
catalyt
domain
indic
exist
function
unrel
activ
polioviru
replic
would
interest
determin
whether
similar
situat
could
observ
hcv
other
shown
requir
hcv
replic
howev
preclud
exist
addit
function
unrel
activ
hcv
replic
would
interest
determin
whether
mutant
local
golgi
could
rescu
infect
inhibit
bfa
deplet
addit
suggest
involv
replic
polioviru
absenc
inhibit
hcv
infect
bfa
cell
strongli
suggest
bfasensit
factor
requir
hcv
infect
indic
requir
hcv
entri
replic
suggest
would
involv
format
replic
complex
traffick
kinas
format
infect
cell
shown
essenti
replic
sever
posit
rna
virus
hcv
sever
group
provid
compel
evid
involv
hcv
replic
contrast
function
hcv
replic
still
controversi
shown
critic
induc
format
interact
activ
whether
contribut
process
still
unknown
recent
report
produc
recruit
golgi
membran
addit
copi
regul
membran
dynam
earli
secretori
pathway
includ
neg
regul
report
involv
replic
hcv
yet
known
host
factor
regul
format
function
membran
web
function
relat
one
hcv
replic
howev
strike
partner
modul
function
secretori
pathway
noninfect
cell
therefor
even
though
function
hcv
replic
appear
differ
role
regul
secretori
pathway
tempt
specul
viru
subvert
whole
pathway
normal
devot
regul
membran
dynam
secretori
pathway
function
membran
web
